VEDOLIZUMAB IN ELDERLY PATIENTS WITH INFLAMMATORY BOWEL DISEASE IS ASSOCIATED WITH IMPROVED DISEASE OUTCOMES AND LOW RATES OF SERIOUS INFECTION: A SINGLE CENTER REAL WORLD EXPERIENCE

被引：0
|
作者：
Pabla, Baldeep S.
Wong, Rochelle
Kashani, Amir
Scoville, Elizabeth A.
Dalal, Robin
Beaulieu, Dawn
Schwartz, David A.
Horst, Sara N.
机构：
来源：
GASTROENTEROLOGY | 2019年 / 156卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Mo1912
引用
收藏
页码：S883 / S884
页数：2
相关论文
共 50 条
  • [1] REAL WORLD COMPARATIVE RISK OF SERIOUS INFECTION WITH ADALIMUMAB, VEDOLIZUMAB, AND INFLIXIMAB IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Osterman, Mark T.
    Long, Millie D.
    Singh, Siddharth
    Meyer, Nicole
    Feng, Chaoling
    Higgins, Kate
    Hepp, Zsolt
    Arikan, Dilek
    Wang, Anthony
    Feagan, Brian G.
    GASTROENTEROLOGY, 2018, 154 (06) : S365 - S365
  • [2] Real World Experience of Vedolizumab in Pediatric Inflammatory Bowel Disease
    Whitney, Annette
    Sarles, Harry E., Jr.
    Claudia, Schroeder P.
    Okoro, Tracy C.
    Van Anglen, Lucinda J.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S396 - S396
  • [3] REAL WORLD EXPERIENCE IN THERAPEUTIC DRUG MONITORING IN INFLAMMATORY BOWEL DISEASE PATIENTS ON VEDOLIZUMAB
    Glassner, Kerri
    Irani, Malcolm
    Malaty, Hoda
    Abraham, Bincy P.
    GASTROENTEROLOGY, 2019, 156 (03) : S36 - S37
  • [4] THERAPEUTIC DRUG MONITORING OF VEDOLIZUMAB FOR PATIENTS WITH INFLAMMATORY BOWEL DISEASE: REAL WORLD EXPERIENCE
    Shalabi, Ahmed
    Banerjee, Rwiti
    Padley, Jessica
    Appleby, Richard
    Johnston, Emma
    GUT, 2021, 70 : A120 - A120
  • [5] REAL WORLD EXPERIENCE IN THERAPEUTIC DRUG MONITORING IN INFLAMMATORY BOWEL DISEASE PATIENTS ON VEDOLIZUMAB
    Glassner, Kerri
    Irani, Malcolm
    Malaty, Hoda
    Abraham, Bincy P.
    INFLAMMATORY BOWEL DISEASES, 2019, 25 : S26 - S26
  • [6] Use of Vedolizumab in Inflammatory Bowel Disease: A Single-Center Experience
    Erdogan, Cagdas
    Yesil, Bayram
    Bacaksiz, Ferhat
    Ari, Derya
    Gokbulut, Volkan
    Yuksel, Mahmut
    Ozin, Yasemin Ozderin
    Kayacetin, Ertugrul
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2022, 33 (10): : 831 - 837
  • [7] Experience with Ustekinumab and Vedolizumab in Inflammatory Bowel Disease Patients: Single-Center Data
    Kandemir, H.
    Karatas, A.
    Moral, K.
    Bilican, G.
    Kekilli, M.
    Cindoruk, M.
    Karakan, T.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1392 - i1393
  • [8] REAL WORLD OUTCOMES OF VEDOLIZUMAB FOR INFLAMMATORY BOWEL DISEASE POST LIVER TRANSPLANTATION
    Peverelle, Matthew
    Mills, Christopher D.
    Testro, Adam
    De Cruz, Peter
    GASTROENTEROLOGY, 2018, 154 (06) : S845 - S845
  • [9] Real-world efficacy and safety of vedolizumab among patients with inflammatory bowel disease: A single tertiary medical center experience in Central Taiwan
    Chiu, Yu-Chiao
    Chen, Chia-Chang
    Ko, Chung-Wang
    Liao, Szu-Chia
    Yeh, Hong-Zen
    Chang, Chung-Hsin
    ADVANCES IN DIGESTIVE MEDICINE, 2021, 8 (01) : 40 - 46
  • [10] Single-Center Experience of Vedolizumab in Patients With Inflammatory Bowel Disease: Does Age Matter?
    Morganstern, Bradley
    Singh, Namita
    Targan, Stephan
    Landers, Carol J.
    Nguyen, Minh
    Vasiliauskas, Eric A.
    Shih, David
    Feldman, Edward J.
    Ippoliti, Andrew
    McGovern, Dermot
    Dubinsky, Marla
    Rabizadeh, Shervin
    Melmed, Gil Y.
    GASTROENTEROLOGY, 2015, 148 (04) : S250 - S250
12345